Omega Seamaster Men
service, GMP cell banking, analytical and process development, scale up, toxicology and GMP supplies, as well as stability studies and QP release for clinical trials.
To support the discovery of drug candidates Alligator Bioscience is using its two pipeline enabling technologies: a fully human scFv antibody library (SCALA 11) and a proprietary protein optimization technology FIND (Fragment INduced Diversity).
PolyTherics and Alligator Bioscience Announce Strategic Collaboration Kythera Biopharmaceuticals Receives $33.3 Million in Payments From Bayer HealthCare (BAY)
Alligator Bioscience discovers and develops innovative biotherapeutics for cancer. Drug discovery and development at Alligator Bioscience spans early research Omega Seamaster Men phases with lead identification up to proof of concept phase I/II studies in patients. Alligator Bioscience has three proprietary projects in its Omega Speedmaster Professional Moonphase
June 12, 2012 Cobra Biologics, the international clinical and commercial manufacturer of biologics and pharmaceuticals and Alligator Bioscience AB today announce that they have entered into a manufacturing services and supply agreement for the production of monoclonal antibody Drug Substance and Drug Product for pre clinical studies and Phase I II clinical trials.
Peter Coleman, CEO of Cobra Biologics said: "Having been through a rigorous selection process, we are very pleased to have been chosen by Alligator. We believe that our comprehensive service offering, right from our excellent cell line development capability through to fill/finish at our recently acquired Matfors facility (Sweden) enabled us to win this important program with Alligator in a highly competitive market place. We look forward to building a lasting relationship with Alligator Bioscience."
Cobra Biologics is a leading international clinical and commercial manufacturer of biologics and pharmaceuticals with three GMP approved facilities. We offer a broad range of integrated and stand alone development services, stretching from cell line development through to the commercial supply of investigational medicinal product. We take pride in manufacturing excellence and being a trusted provider, delivering what we promise and helping our customers to develop drugs for the benefit of patients. Cobra Biologics provides manufacturing solutions to the biologics and pharmaceutical industry covering antibodies, recombinant proteins, viruses, DNA, cellular therapeutics and small molecules.
Alligator Bioscience To Address Immunogenicity With Epibase(R) Forest Laboratories, Inc. (FRX) Coughs Up $25 Million for Nabriva Therapeutics's Phase II Antibacterial, Right to Take Over Company
Alligator Bioscience is a privately held company based in Lund, Sweden.
TAP Biosystems Announce New Webinar Program on Applications of Micro Bioreactors Specialists at Cobra Biologics Ltd. and TAP Discuss Advances in Bioprocess Development Protalix Biotherapeutics, Inc. (PLX) Gets $25 Million Payment From Pfizer Inc. (PFE)
Under the terms of the agreement, Cobra will be providing cell line development through its maxXpress Omega Speedmaster 50th Anniversary
Alligator will be taking advantage of Cobra's maxXpress service, which combines the UCOE protein expression technology with the experience and expertise of Cobra Biologics' cell line development team and the Cello robotic clone selection system, to enable rapid clone selection and production of the monoclonal antibody.
Cobra Biologics Ltd.' Expansion Continues Eli Lilly and Company (LLY) CEO: No Mega Pharma Deals for Omega Speedmaster Vs Tudor Black Bay
Cobra Biologics Ltd and Alligator Bioscience Sign Monoclonal Antibody Manufacturing Agreement
Cobra Biologics Ltd. Acquires Unitech Pharma Group to Expand its Capacity and Biopharmaceutical Service Offering Foundation Medicine, Novartis AG (NVS) Ink Pact to Provide Genomic Information for Clinical Oncology Programs
Omega Seamaster Men
Omega Seamaster 007
Copyright 2006–2007 Phoenix Gallery. All rights reserved. Site design by . . . || mccallum design